Takeda Pharmaceutical Company Limited (TKPYY)
-OTC Markets 23.52 Oct 1, 3:49PM EDT|Pre-Market
:
NaN
| Prev Close: | 23.52 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 21.68 - 27.87 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 16,955 |
|---|
| Market Cap: | 37.14B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Amgen's 10 Billion Dollar Moleculeat Seeking Alpha(Mon, Sep 30)
- AMAG Shares Skid on FDA NotificationZacks(Thu, Sep 26)
- Could This Popular Diabetes Treatment Also Treat Alzheimer's Disease?at Motley Fool(Thu, Sep 26)
- EU Nod for Furiex Diabetes DrugsZacks(Wed, Sep 25)
- Data on Pomalyst PublishedZacks(Fri, Sep 6)
- Priority Review for Takeda CandidateZacks(Thu, Sep 5)
- Diabetes Drugmakers and Their "Definitely Maybe" Momentat Motley Fool(Wed, Sep 4)
- Positive Data on Takeda's AlogliptInZacks(Tue, Sep 3)
- The Zacks Analyst Blog Highlights: Takeda Pharmaceutical Company, Pfizer, Novartis, Actelion and Wal-Mart StoresZacks(Fri, Aug 30)
- Takeda/Zinfandel Initiate AD StudyZacks(Thu, Aug 29)
- Orexigen Provides Contrave UpdateZacks(Wed, Aug 28)
- Millicom CFO Francois-Xavier Roger to leave company August 31theflyonthewall.com(Mon, Aug 26)
- Swiss Approval for Takeda/ Dainippon's LatudaZacks(Mon, Aug 19)
- Narrower-than-Expected Q2 Loss at AlnylamZacks(Wed, Aug 14)
- New Patent Issued for AMAG's FerahemeZacks(Fri, Aug 9)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.86 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Takeda Pharmaceutical Company Limited is engaged in supplying pharmaceutical products worldwide. The company provides products in various therapeutic areas, including cardiovascular and metabolic, oncology, central nervous system, respiratory and ...
View More
0.41%